AZD2171
All > Medicine > Cancer
- A substance being studied in the treatment of some types of cancer. AZD2171 blocks the growth of new blood vessels needed for tumors to grow and may kill cancer cells. It is a type of angiogenesis inhibitor and a type of vascular endothelial growth factor (VEGF) receptor tyrosine kinase inhibitor. Also called cediranib and Recentin.
National Cancer Institute - Cite This Source - This Definition - axitinib, AZD0530, BIBF 1120, cediranib, CT53518, MLN518, MP470, Recentin, tandutinib, tyrosine kinase inhibitor, tyrosine kinase inhibitor BIBF 1120, vandetanib, vascular endothelial growth factor receptor tyrosine kinase inhibitor, VEGFR tyrosine kinase inhibitor, XL880, Zactima